Oropharyngeal administration of mother's milk to prevent necrotizing enterocolitis in extremely low-birth-weight infants: Theoretical perspectives

Journal of Perinatal and Neonatal Nursing

Volumn 29, Issue 1, 2015, Pages 81-90

  Rodriguez, Nancy A ^a,b   Caplan, Michael S ^a,b  

^a NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Breast milk; Buccal; Colostrum; Extremely low birth weight; Human milk; Immune; Infection; Mother's milk; Mouth care; NEC; Necrotizing enterocolitis; Oral care; Oral colostrum; Oral immune therapy; Oropharyngeal; Premature; Preterm; Very low birth weight

Indexed keywords

BREAST MILK; ENTEROCOLITIS, NECROTIZING; EXTREMELY LOW BIRTH WEIGHT; HUMAN; MOUTH MUCOSA; MUCOSAL DRUG ADMINISTRATION; NEWBORN; NURSE ATTITUDE; OROPHARYNX; PATHOPHYSIOLOGY; PHYSIOLOGY; PREMATURITY;

ADMINISTRATION, MUCOSAL; ENTEROCOLITIS, NECROTIZING; HUMANS; INFANT, EXTREMELY LOW BIRTH WEIGHT; INFANT, EXTREMELY PREMATURE; INFANT, NEWBORN; MILK, HUMAN; MOUTH MUCOSA; NURSE'S ROLE; OROPHARYNX;

EID: 84989328539     PISSN: 08932190     EISSN: 15505073     Source Type: Journal    
DOI: 10.1097/JPN.0000000000000087     Document Type: Article

References (96)

1. Caplan MS. Neonatal necrotizing enterocolitis. Introduction. Semin Perinatol. 2008;32(2):69.
2. Sallah W, Perlman J, Silver I, Broyles R. Necrotizing enterocolitis and neurodevelopmental outcome in extremely lowbirth-weight infants. J Perinatol. 2004;24:534-540.
3. Yajamanyam PK, Rasiah SV, Ewer AK. Necrotizing enterocolitis: current perspectives. Res Rep Neonatol. 2014;4:31-42.
4. Shah TA, Meinzen-Derr J, Gratton T, et al. Hospital and neurodevelopmental outcomes of extremely low-birth-weight infants with necrotizing enterocolitis and spontaneous intestinal perforation. J Perinatol. 2012;32(7):552-558.
5. Claud EC, Walker WA. Bacterial colonization, probiotics and necrotizing enterocolitis. J Clin Gastroenterol. 2008;42:S46-S51.
6. Frost BL, Caplan MS. Necrotizing enterocolitis: pathophysiology, platelet-activating factor, and probiotics [review]. Semin Pediatr Surg. 2013;22(2):88-93.
7. Wagner CL, Taylor SN, Johnson D. Host factors in amniotic fluid and breast milk that contribute to gut maturation. Clin Rev Allergy Immunol. 2008;34(2):191-204.
8. Hirai C, Ichiba H, Saito M, Shintaku H, Yamano T, Kusuda S. Trophic effect of multiple growth factors in amniotic fluid or human milk on cultured human fetal small intestinal cells. J Pediatr Gastroenterol Nutr. 2002;34(5):524-528.
9. Mller HK, Fink LN, Sangild PT, Fr Ki RH. Colostrum and amniotic fluid from different species exhibit similar immunomodulating effects in bacterium-stimulated dendritic cells. J Interferon Cytokine Res. 2011;31(11):813-823.
10. Sullivan SE, Calhoun DA, Maheshwari A, et al. Tolerance of simulated amniotic fluid in premature neonates. Ann Pharmacother. 2002;36(10):1518-1524.
11. Sisk PM, Dillard RG, Gruber KJ, O'Shea TM. Early human milk feeding is associated with a lower risk of necrotizing enterocolitis in very low-birth-weight infants. J Perinatol. 2007;27(12):428-433.
12. Schanler RJ. Evaluation of the evidence to support the current recommendations to meet the needs of premature infants: the role of human milk. Am J Clin Nutr. 2007;85(2):625S-628S.
13. Meier PP, Engstrom JL, Patel AL, Jegier BJ, Bruns NE, Improving the use of human milk during and after the NICU stay. Clin Perinatol. 2010;37(1):217-245.
14. Patel AL, Johnson TJ, Engstrom JL, et al. Impact of early human milk on sepsis and healthcare costs in very low-birthweight infants. J Perinatol. 2013;33(7):1-6.
15. Quigley MA, Henderson G, Anthony MY, McGuire W. Formula milk versus donor breast milk for feeding preterm or low birth weight infants. Cochrane Database Syst Rev. 2007;(4):CD002971.
16. Sodhi C, Richardson W, Gribar S, Hackam DJ. The development of animal models for the study of necrotizing enterocolitis. Dis Model Mech. 2008; 1(2-3):94-98.
17. Dvorak B, Halpern MD, Holubec H, et al. Epidermal growth factor reduces the development of necrotizing enterocolitis in a neonatal rat model. Am J Physiol Gastrointest Liver Physiol. 2002;282:G156-G164.
18. Feng J, El-Assal ON, Besner GE. Heparin-binding epidermal growth factor-like growth factor reduces intestinal apoptosis in neonatal rats with necrotizing enterocolitis. J Pediatr Surg. 2006;41:742-747.
19. Maheshwari A, Kelly DR, Nicola T, et al. TGF-beta 2 suppresses macrophage cytokine production and mucosal inflammatory responses in the developing intestine. Gastroenterology. 2011;140(1):242-253.
20. Yu Y, Shiou SR, Guo Y, et al. Erythropoietin protects epithelial cells from excessive autophagy and apoptosis in experimental neonatal necrotizing enterocolitis [electronic resource]. PLoS One. 2013;8(7):e69620.
21. Lu J, Jilling T, Li D, Caplan MS. Polyunsaturated fatty acid supplementation alters proinflammatory gene expression and reduces the incidence of necrotizing enterocolitis in a neonatal rat model. Pediatr Res. 2007;61:427-432.
22. Edde L, Hipolito RB, Hwang FF, Headon DR, Shalwitz RA, Sherman MP. Lactoferrin protect neonatal rats from gutrelated systemic infection. Am J Physiol Gastrointest Liver Physiol. 2001;281:G1140-G1150.
23. Emami CN, Chokski N, Wang J, et al. Role of interleukin-10 in the pathogenesis of necrotizing enterocolitis. Am J Surg. 2012;203(4):428-435.
24. Jantscher-Krenn E, Zherebtsov M, Nissan C, et al. The human milk oligosaccharide disialyllacto-N-tetraose prevents necrotising enterocolitis in neonatal rats. Gut. 2012;61(10):1417-1425.
25. Newburg DS, Walker WA. Protection of the neonate by the innate immune system of developing gut and of human milk. Pediatr Res. 2007;95(6):1075-1081.
26. Walker A. Breast milk as the gold standard for protective nutrients. J Pediatr. 2010;156:S3-S7.
27. Donovan SM. Role of human milk components in gastrointestinal development: current knowledge and future needs. J Pediatr. 2006;149:S49-S61.
28. Underwood MA, Gilbert WM, Sherman MP. Amniotic fluid: not just fetal urine anymore. J Perinatol. 2005;25:341-348.
29. Koenig A, de Albuquerque Diniz EM, Barbosa SF, Vaz FA. Immunologic factors in human milk: the effects of gestational age and pasteurization. J Hum Lact. 2005;21:439-443.
30. Ronayne de Ferrer PA, Baroni A, Sambucetti ME, Lopez NE, Cernadas JMC. Lactoferrin levels in term and preterm milk. J Am Coll Nutr. 2000;19:370-373.
31. Araujo ED, Goncalves AK, Cornetta M, et al. Evaluation of the secretory immunoglobulin A levels in the colostrum and milk of mothers of term and preterm infants. Braz J Infect Dis. 2005;9:357-362.
32. Dvorak B, Fituch CC, Williams CS, Hurst NM, Schanler RJ. Increased epidermal growth factor levels in human milk of mothers with extremely premature infants. Pediatr Res. 2003;54:15-19.
33. Davidson B, Meinzen-Derr JK, Wagner CL, Newburg DS, Morrow AL. Fucosylated oligosaccharides in human milk in relation to gestational age and stage of lactation. Adv Exp Med Biol. 2004;554:427-430.
34. Bocci V. Absorption of cytokines via oropharyngeal associated lymphoid tissues. Clin Pharmacokinet. 1991;21: 411-417.
35. Bocci V. The oropharyngeal delivery of interferons: where are we and where do we need to go? J Interferon Cytokine Res. 1999;19:859-861.
36. Rodriquez N, Meier P, Groer M, Zeller J. Oropharyngeal administration of colostrum to extremely low-birth-weight infants: theoretical perspectives. J Perinatol. 2009;29:1-7.
37. Butcher E, Picker L. Lymphocyte homing and homeostasis. Science. 1996;272:60-66.
38. Tovoy MG, Meritet JF, Guymarho J, Maury C. Mucosal cytokine therapy: marked antiviral and antitumor activity. J Interferon Cytokine Res. 1999;19(8):911-921.
39. Garofalo R. Cytokines in human milk [review]. J Pediatr. 2010;156:(2 suppl):536-540.
40. Eiwegger T, Stahl B, Haidl P, et al. Prebiotic oligosaccharides: in vitro evidence for gastrointestinal epithelial transfer and immunomodulatory properties. Pediatr Allergy Immunol. 2010;21(8):1179-1188.
41. Koldovsky O. The potential physiologic significance of milkborne hormonally active substances for the neonate. J Mammary Gland Biol Neoplasia. 1996;1(3):317-323.
42. Purushotham KR, Offenmuller K, Bui AT, et al. Absorption of epidermal growth factors occurs through the gastrointestinal tract and oral cavity in adult rats. Am J Physiol. 1995;269 (6, pt 1):G867-G873.
43. Dvorak B, Khailova L, Clark J, et al. Comparison of epidermal growth factor and Heparin-binding epidermal growth factorlike growth factor for prevention of experimental necrotizing enterocolitis. J Pediatr Gastroenterol Nutr. 2008;47(1):11-18.
44. Oguchi S, Shinohara K, Yamashiro Y, Walker WA, Sanderson IR. Growth factors in breast milk and their effect on gastrointestinal development [review] [38 refs]. Chung-Hua Min Kuo Hsiao Erh Ko i Hsueh Hui Tsa Chih. 1997;38(5):332-337.
45. Castellote C, Casillas R, Ramirez-Santana C, et al. Premature delivery influences the immunological composition of colostrum and transitional and mature human milk. J Nutr. 2011;141(6):1181-1187.
46. Donovan SM, Wang M, Friedberg I, Schwartz SL, Chapkin RS. Host-microbe interactions in the neonatal intestine: role of human milk oligosaccharides. Adv Nutr. 2012;3:450S-455S.
47. Newburg DS. Oligosaccharides in human milk and bacterial colonization. J Pediatr Gastroenterol Nutr. 2000;30:S8-S17.
48. Boehm G, Stahl B. Oligosaccharides from milk. J Nutr. 2007;137(3):847S-849S.
49. Coppa GV, Zampini L, Galeazzi T, et al. Human milk oligosaccharides inhibit the adhesion of caco-2 cells of diarrheal pathogens: Escherichia coli, Vibrio cholerae and Salmonella fyris. Pediatr Res. 2006;59(3):377-382.
50. Eiwegger T, Stahl B, Schmitt J, et al. Human milk-derived oligosaccharides and plant-derived oligosaccharides stimulate cytokine production of cord blood T-cells in vitro. Pediatr Res. 2004;56(4):536-540.
51. Haversen LA, Baltzer L, Dolphin G, Hanson LA, Mattsby-Baltzer I. Antiinflammatory activities of human lactoferrin in acute dextran sulphate-induced colitis in mice. Scand J Immunol. 2003;57:2-10.
52. Haversen L, Ohlsson BG, Hahn-Zoric M, Hanson LA, Mattsby-Baltzer I. Lactoferrin down-regulates the LPS-induced cytokine production in monocytic cells via NF-kappaB. Cell Immunol. 2002;220:83-95.
53. Shoji H, Oguchi S, Shinohara K, Shimizu T, Yamashiro Y. Effects of iron-saturated human lactoferrin on hydrogen peroxide-induced oxidative damage in intestinal epithelial cells. Pediatr Res. 2007;61(1):89-92.
54. Hamosh M. Protective function of protein and lipids in human milk. Biol Neonate. 1998;74:163-176.
55. Mattsby-Baltzer I, Roseanu A, Motas C, Elverfors J, Engberg I, Hanson LA. Lactoferrin or a fragment thereof inhibits the endotoxin-induced interleukin-6 response in human monocyte cells. Pediatr Res. 1996;40:257-262.
56. Mechnicki M, Zimecki M, Zaguski T. Lactoferrin regulates the release of tumor necrosis factor alpha and inteeleukin-6 in vivo. Int J Exp Pathol. 1993;74:433-439.
57. Peterson JA, Patton S, Hamosh M. Glycoproteins of the human milk fat globule in the protection of the breast-fed infant against infections. Biol Neonate. 1998;74:143-162.
58. Xanthou M. Immune protection of human milk. Biol Neonate. 1998;74:121.
59. Goldman AS, Chheda S, Keeney S, Schmalstieg FC, Schanler R. Immunologic protection of the premature newborn by human milk. Semin Perinatol. 1994;18(6):495-501.
60. Goldblum RM, Schanler RJ, Garza C, Goldman AS. Human milk feedings enhances the urinary excretion of immunologic factors in low-birth-weight infants. Pediatr Res. 1989;25:184-188.
61. Goldman AS, Garza C, Schanler RJ, Goldblum RM. Molecular forms of lactoferrin in stool and urine from infants fed human milk. Pediatr Res. 1990;27(3):252-255.
62. Hutchens TW, Henry JF, Yip TT. Purification and characterization of intact lactoferrin found in the urine of human milk-fed preterm infants. Clin Chem. 1989;35(9):1928-1933.
63. Hutchens TW, Henry JF, Yip T. Origin of intact lactoferrin and its DNA-binding fragments found in the urine of human milkfed preterm infants. Evaluation by stable isotope enrichment. Pediatr Res. 1991;29:243-250.
64. Hutchens TW, Henry JF, Yip TT. Structurally intact (78-kDa) forms maternal lactoferrin purified from urine of preterm infants fed human milk: identification of a trypsin-like proteolytic cleavage event in vivo that does not result in fragment dissociation. Proc Nat Acad Sci USA. 1991;88(8):2994-2998.
65. Rodriguez NA, Meier PP, Groer MW, et al. A randomized clinical trial of the oropharyngeal administration of mother's colostrum to extremely low-birth-weight infants in the first days of life. Neonatal Intensive Care J Perinatol Neonatol. 2011;24(4):31-35.
66. Brandtzaeg P. Mucosal immunity: integration between mother and the breast-fed infant. Vaccine. 2003;21(24):3382-3388.
67. Garofalo RP, Goldman AS. Cytokines, chemokines and colony-stimulating factors in human milk: the 1997 update. Biol Neonate. 1998;74:134-142.
68. Julius MH, Janusz M, Lisowski J. A colostral protein that induces the growth and differentiation of resting B lymphocytes. J Immunol. 1988;140:1366-1371.
69. Juto P. Human milk stimulates B cell function. Arch Di Child. 1985;60:610-613.
70. Caplan MS, Amer M, Jilling T. The role of human milk in necrotizing enterocolitis. In: Davis MK, Isaacs CE, Hanson LA, Wright AL, eds. Integrating Population Outcomes, Biological Mechanisms, and Research Methods in the Study of Human Milk and Lactation. New York, NY: Plenum; 2002.
71. Buescher ES. Anti-inflammatory characteristics of human milk: how, where and why. Adv Exp Med Biol. 2001;501:207-222.
72. Kotey FO, Spatz DL. White matter injury in preterm infants. Could human milk play a role in its prevention? Adv Neonatal Care. 2013;13(2):89-94.
73. Lopez AM. Proteins in human milk. Breastfeed Rev. 2007;15(1):15-16.
74. Dvorak B, Halpern MD, Holubec H, Dvorakova K, Dominguez JA, Williams CS. Maternal milk reduces severity of necrotizing enterocolitis and increases intestinal IL-10 in a neonatal rat model. Pediatr Res. 2003;53(3):426-433.
75. Field CJ, Thomson CA, Van Aerde JE, et al. Lower proportion of CD45RO+ Cells and deficient interleukin-10 production by formula-fed infants, compared with human-fed, is corrected with supplementation of long-chain polyunsaturated fatty acids. J Pediatr Gastroenterol Nutr. 2000;31:291-299.
76. Chichlowski M, De Lartigue G, German JB, Raybould HE, Mills DA. Bifidobacteria isolated from infants and cultured on human milk oligosaccharides affect intestinal epithelial function. J Pediatr Gastroenterol Nutr. 2012;55(3):321-327.
77. Koojman R, Coppens A. Insulin-like growth factor stimulates IL-10 production in human T cells. J Luekoc Biol. 2004;76:862-867.
78. Rautava S, Nanthakumar NN, Dubert-Ferrandon A, Lu L, Rautava J, Walker WA. Breast milk-transforming growth factor-beta 2 specifically attenuates Il-beta-induced inflammatory responses in the immature human intestine via an SMAD6- and ERK-dependent mechanism. Neonatology. 2011;99:192-201.
79. Mehta R, Petrova A. Very preterm gestation and breast milk cytokine content during the first month of lactation. Breastfeed Med. 2011;6(1):21-24.
80. Zarban A, Taheri F, Chahkandi T, Sharifzadeh G, Khorashadizadeh M. Antioxidant and radical scavenging activity of human colostrum, transitional and mature milk. J Clin Biochem Nutr. 2009;45(2):150-154.
81. Eguchi M, Miyazaki T, Masatsuji-Kato E, et al. Cytoprotection against ischemia-induced DNA cleavages and cell injuries in the rat liver by pro-vitamin C via hydrolytic conversion into ascorbate. Mol Cell Biochem. 2003;252(1-2):17-23.
82. Vento M, Moro M, Escrig R, et al. Preterm resuscitation with low oxygen causes less oxidative stress, inflammation, and chronic lung disease. Pediatrics. 2009;124(3): e439-e49.
83. Vento M. Oxygen supplementation in the neonatal period: changing the paradigm. Neonatology. 2014;105:323-331.
84. Ledo A, Arduini A, Asensi MA, et al. Human milk enhances antioxidant defenses against hydroxyl radical aggression in preterm infants. Am J Clin Nutr. 2009;89(1):210-215.
85. Xavier AM, Rai K, Hegde AM. Total antioxidant concentrations of breast milk-an eye opener to the negligent. J Health Popul Nutr. 2011;29:605-611.
86. Puertollano MA, Puertollano E, Alvarez de Cienfuegos G, de Pablo MA. Dietary antioxidants: immunity and host defense. Curr Top Med Chem. 2011;11:1752-1766.
87. Rodriguez NA, Meier PP, Groer M, et al. A pilot study to determine the safety and feasibility of oropharyngeal administration of own mother's colostrum to extremely lowbirth-weight infants. Adv Neonatal Care. 2010;10(4):206-212.
88. Seigel JK, Smith B, Ashley P, et al. Early administration of oropharyngeal colostrum to extremely low-birth-weight infants. Breastfeeding Med. 2013;8:491-495.
89. Wilson S, Taylor C, Root K, Blackman A, Kaufman D. Oral care in the neonate: one step in a bundle to reduce ventilator associated pneumonia (VAP). Paper presented at: Pediatric Academic Societies (PAS) 2012 Annual Meeting; April 28 to May 1, 2012; Boston, MA. E-PAS:2012:1519. 349.
90. Olsen J. Implementation of oropharyngeal administration of colostrum in the NICU. Paper presented at: Vermont Oxford Network Annual Meeting; December 3-4, 2011; Washington, DC.
91. McCallie KR, Lee HC, Mayer O, Cohen RS, Hintz SR, Rhine WD. Improved outcomes with a standardized feeding protocol for very low-birth-weight infants. J Perinatol. 2011;31(suppl 1):S61-S67.
92. Steffen E, Vangvanichyakorn K, Sun S. Implementing a bundle of potentially better practices (PBP) to reduce NEC rate in VLBW infants. Paper presented at: Vermont Oxford Network Annual Meeting; December 3-4, 2011; Washington, DC.
93. Caprio MC, Barr PA, Kim Y, Cruz H. Effects of establishing a feeding protocol to improve nutrition in premature neonates. Paper presented at: Pediatric Academic Societies (PAS) Annual Meeting; May 4-7, 2013; Washington, DC; E-PAS 2013: 3840.672.
94. Thibeau S, Boudreaux C. Exploring the use of mother's own milk as oral care for mechanically ventilated very low-birthweight infants. Adv Neonatal Care. 2013;13(3):190-197.
95. Gephart SM, Weller M. Colostrum as oral immune therapy to promote neonatal health. Adv Neonatal Care. 2014;14: 44-51.
96. Flidel-Rimon O, Friedman S, Lev E, Juster-Reicher A, Armitay M, Shinwell ES. Early enteral feeding and nosocomial sepsis in very low birthweight infants. Arch Dis Child Fetal Neonatal Ed. 2004;89:F289-F292.